This transition reflects a planned and strategic evolution of MC2 Therapeutics, aligned with the company’s focus on commercial expansion.

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow's standard-of-care to cure cancer and infectious diseases, is honored to share that it was awarded ...

Years before Novo Nordisk's obesity drug Wegovy became a U.S. blockbuster, then-CEO Lars Rebien Sorensen told a press conference in Copenhagen: "You ain't seen nothing yet." May 22, 2025 Cigna to ...

In an effort to maximize the earnings potential of its plaque psoriasis cream, Danish dermatology biotech MC2 Therapeutics ...

As previously announced, Kathryn Leaf has assumed the role of Chief Executive Officer, while Jeff Miller is now Chief Investment Officer. Kathryn and Jeff both joined Pantheon in 2008, and most ...

Complete digital access to quality FT journalism with expert analysis from industry leaders. Pay a year upfront and save 20%.